Review article: the economic impact of the irritable bowel syndrome

QR Code

Review article: the economic impact of the irritable bowel syndrome

Background: Irritable bowel syndrome (IBS) is a chronic functional disorder of the gastrointestinal system affecting a large number of people worldwide. Whilst it has no attributable mortality, it has substantial impact on patients' quality of life (QoL) and is associated with considerable heal...

Full description

Bibliographic Details
Main Authors:	Canavan, Caroline, West, Joe, Card, Timothy R.
Format:	Article
Published:	Wiley 2014
Online Access:	https://eprints.nottingham.ac.uk/39272/

Similar Items

The epidemiology of irritable bowel syndrome
by: Canavan, Caroline, et al.
Published: (2014)

The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: a cohort study
by: Canavan, Caroline, et al.
Published: (2014)

Change in quality of life for patients with irritable bowel syndrome following referral to a gastroenterologist: a cohort study
by: Canavan, Caroline, et al.
Published: (2015)

Calculating total health service utilisation and costs from routinely collected electronic health records using the example of patients with irritable bowel syndrome before and after their first gastroenterology appointment
by: Canavan, Caroline, et al.
Published: (2015)

Using real world data to generate health economic models: a worked example assessing the cost-effectiveness of referral to gastroenterology for irritable bowel syndrome in the UK
by: Canavan, Caroline
Published: (2016)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
by: Major, Giles, et al.
Published: (2014)

Distinct abnormalities of small bowel and regional colonic volumes in subtypes of irritable bowel syndrome revealed by MRI
by: Lam, Ching, et al.
Published: (2016)

The Studies of Traditional Chinese Medicine Symptomology on Irritable Bowel Syndrome
by: Chiang, Willie Vui Yuan
Published: (2015)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
by: Garsed, Klara, et al.
Published: (2013)

Are IBD patients more likely to have a prior diagnosis of irritable bowel syndrome?: report of a case-control study in the General Practice Research Database
by: Card, Timothy R., et al.
Published: (2014)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
by: Tooth, David, et al.
Published: (2014)

Dietary fibre intervention for gut microbiota, sleep and mental health in adults with irritable bowel syndrome: A scoping review
by: Yan, R., et al.
Published: (2021)

Colonic response to laxative ingestion as assessed by MRI differs in constipated irritable bowel syndrome compared to functional constipation
by: Lam, C., et al.
Published: (2016)

Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome
by: Major, Giles, et al.
Published: (2017)

Biomarkers to assess an anti-inflammatory treatment for irritable bowel syndrome: mast cell assays and magnetic resonance imaging
by: Lam, Ching Yin
Published: (2015)

The cognitive behavioural treatment of irritable bowel syndrome: feasibility of a nurse delivered model of guided self-help
by: Dainty, Andrew David
Published: (2016)

Associations of self-reported physical activity levels and lifestyle risk factors with irritable bowel syndrome severity scores
by: Yu, Chang Zhuang
Published: (2021)

Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial MRI
by: Pritchard, Susan E., et al.
Published: (2013)

Prevalence of irritable bowel syndrome and its association with perceived stress level at the International Islamic University Malaysia among nursing students
by: Mohammed Abdullah Al-Mahmood, Sinan, et al.
Published: (2018)

A contribution to knowledge of the aetiology and indirect impact of inflammatory bowel diseases: (based upon analysis of routinely and semi-routinely available data)
by: Card, Timothy R.
Published: (2004)

Predicting the response to Ondansetron, a 5HT3 receptor antagonist, in irritable bowel syndrome with diarrhoea: the utility of clinical features and objective biomarkers
by: Garsed, Klara C.
Published: (2014)

A mechanistic multi-centre, parallel group, randomised placebo controlled trial of Mesalazine for treatment of irritable bowel syndrome with diarrhoea (IBS-D)
by: Lam, Ching, et al.
Published: (2015)

Development, content validity and cross-cultural adaptation of a Patient-Reported Outcome Measure for Real-time Symptom Assessment in Irritable Bowel Syndrome
by: Vork, L., et al.
Published: (2017)

Prevalence of irritable bowel syndrome(IBS)among healthy subjects using valida ted Bahasa Malaysia version of rome lll IBS questionnaire
by: Anuar, Waid
Published: (2008)

Translation and validation of Malay language version of the patient-physician relationship survey (PPRS) (patient version) and determinants of an effective patient-physician relationship in the management of irritable bowel syndrome
by: Ling, Ooi Seok
Published: (2021)

The effect of brisk walking exercise on immune function, intestinal fatty acid binding protein, fatigue and severity scores in patients with irritable bowel syndrome : a randomised controlled trial
by: Rooshdi, Raja Abdul Wafy Raja Muhammad
Published: (2020)

In Vitro And In Vivo Phenotypic Studies To Characterize Blastocystis Sp. Subtype 3 (ST3) Isolated From Asymptomatic Individuals, Symptomatic And Irritable Bowel Syndrome (IBS) Patients / Nanthiney Devi Ragavan
by: Nanthiney Devi, Ragavan
Published: (2016)

Adverse pregnancy outcomes among women with inflammatory bowel disease: a population based study from England
by: Abdul Sultan, Alyshah, et al.
Published: (2016)

Assessment of low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) on clinical, psychology and quality of life outcomes assessed in patient with irritable bowel syndrome (IBS) in Hospital Universiti Sains Malaysia (HUSM), Kelantan
by: Isa, Adib Mat
Published: (2020)

Risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity
by: Chu, Thomas P.C., et al.
Published: (2018)

Extra-gastrointestinal manifestations of inflammatory bowel disease may be less common than previously reported
by: Card, Timothy R., et al.
Published: (2016)

Interventions for preventing occupational irritant hand dermatitis (Review)
by: Bauer, Andrea, et al.
Published: (2018)

Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial
by: Yan, R., et al.
Published: (2020)

The pattern of underlying cause of death in patients with inflammatory bowel disease in England: a record linkage study
by: Chu, Thomas P.C., et al.
Published: (2016)

Antiphospholipid Syndrome presenting as mesenteric vein thrombosis and gangrenous small bowel
by: Wan Ali, Wan Ahmad Syahril Rozli, et al.
Published: (2011)

Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding
by: Crooks, Colin John, et al.
Published: (2013)

Excess long-term mortality following non-variceal upper gastrointestinal bleeding: a population-based cohort study
by: Crooks, Colin John, et al.
Published: (2013)

A comparison of the recording of comorbidity in primary and secondary care by using the Charlson Index to predict short-term and long-term survival in a routine linked data cohort
by: Crooks, Colin J., et al.
Published: (2015)

The use of a bayesian hierarchy to develop and validate a co-morbidity score to predict mortality for linked primary and secondary care data from the NHS in England
by: Crooks, Colin J., et al.
Published: (2016)

Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study
by: Ban, Lu, et al.
Published: (2015)